Autologous olfactory mucosa mesenchymal stem cells treatment improves the neural network in chronic refractory epilepsy

BACKGROUND AND AIMS: Refractory epilepsy is also known as drug-resistant epilepsy with limited clinical treatment. Benefitting from its safety and easy availability, olfactory mucosa mesenchymal stem cells (OM-MSCs) are considered a preferable MSC source for clinical application. This study aims to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zheng-Zhao, Huang, Yan, Hong, Chun-Gu, Wang, Xin, Duan, Ran, Liu, Jian-Yang, He, Jia-Lin, Duan, Da, Xie, Hui, Lu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483711/
https://www.ncbi.nlm.nih.gov/pubmed/37674249
http://dx.doi.org/10.1186/s13287-023-03458-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483711/
https://www.ncbi.nlm.nih.gov/pubmed/37674249
http://dx.doi.org/10.1186/s13287-023-03458-6

Ejemplares similares